Position in UTHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,585
New position
Shares Held
14
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#806
of 870 holders
Holding Since
Jun 2026
1 quarter on record
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Park Place Capital Corp holds $531,260 across 7 Drug Manufacturers - Specialty & Generic names. UTHR ranks #4 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,611 | $403,206 | |
| 2 | HLN |
Haleon plc
|
10,562 | $98,543 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
543 | $18,396 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
14 | $7,585 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
16 | $2,696 | |
| 6 | BHC |
Bausch Health Companies Inc.
|
150 | $739 | |
| 7 | VTRS |
Viatris Inc
|
6 | $95 |
All Filings in UTHR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,585 | 14 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||